Community Use of Intravenous Tissue Plasminogen Activator for Acute Stroke
Stroke 32:861-865, Katzan,I.L.,et al, 2001
Delay in Presentation and Evaluation for Acute Stroke
Stroke 32:63-69, Lacy,C.R.,et al, 2001
Cerebellar Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies
Arch Neurol 58:225-230, Honorat,J.,et al, 2001
Intraarterial Thrombolysis: Ready for Prime Time?
AJNR 22:55-58, Executive Committee of the ASITN, 2001
Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated with Symptomatic Intracerebral Hemorrhage
Stroke 32:12-16, Lopez-Yunez,A.M.,et al, 2001
Ataxia Associated with Hashimotos Disease: Progressive Non-Familial Adult Onset Cerebellar Degeneration with Autoimmune Thyroiditis
JNNP 71:81-87, Selim, M. and Drachman, D.A., 2001
Immune Cytopenias as the Presenting Finding in Primary Sjogrens Syndrome
QJM 93:825-829, Schattner,A.,et al, 2000
Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000
Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000
Identification of lacunar Infarcts Before Thrombolysis in the ECASS I Study
Neurol 54:684-688, Toni,D.,et al, 2000
rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000
Stroke Treatment with Tissue Plasminogen Activator in the Setting of Aortic Dissection
Neurol 54:1010, Fessler,A.J. & Alberts,M.J., 2000
Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000
Intravenous tPA in Acute Ischemic Stroke Related to Internal Carotid Artery Dissection
Neurol 54:2159-2161, Derex,L.,et al, 2000
Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis
Stroke 31:1420-1425, Chow,K.,et al, 2000
Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke With Diffusion and Perfusion MRI
Stroke 31:1318-1328, Schellinger,P.D.,et al, 2000
Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000
Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000
Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000
Transcranial Doppler Ultrasound Criteria for Recanalization After Thrombolysis for Middle Cerebral Artery Stroke
Stroke 31:1128-1132, Burgin,W.S.,et al, 2000
Comparison of Diffusion-Weighted MRI and CT in Acute Stroke
Neurol 54:1557-1561,1548,1549,1552, Lansberg,M.G.,et al, 2000
Treatment of Intraventricular Hemorrhage with Urokinase
Stroke 31:841-847, Naff,N.J.,et al, 2000
Stereotactic Computed Tomographic-Guided Aspiration and Thrombolysis of Intracerebral Hematoma
Stroke 31:834-840, Montes,J.M.,et al, 2000
Thrombolytic Reversal of Acute Human Cerebral Ischemic Injury Shown by Diffusion/Perfusion Magnetic Resonance imaging
Ann Neurol 47:462-469, Kidwell,C.S.,et al, 2000
Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000
Intracranial Hemorrhage Associated With Thrombolytic Therapy for Eldery Patients With Acute Myocardial Infarction
Stroke 31:1802-1811, Brass,L.M. et al, 2000
Surgery for Parkinson Disease
Arch Neurol 57:1118-1125, Lang,A.E., 2000
Long-term Effect of Bone-marrow Transplantation for Childhood-onset Cerebral X-linked Adrenoleukodystrophy
Lancet 356:713-718, Shapiro,E. et al, 2000
Transplantation of Cultured Human Neuronal Cells for Patients With Stroke
Neurol 55:565-569, 467, Kondziolka,D. et al, 2000
Orolingual Angioneurotic Edema Following Therapy of Acute Ischemic Stroke with Alteplase
Neurol 55:599-600, Rudolf,J. et al, 2000
Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000
Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies
NEJM 343:847-855, Verning,S. et al, 2000
Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 31:2552-2557, Ernst,R.,et al, 2000
Thrombolytic Therapy in Patients with Acute Ischemic Stroke
Arch Neurol 57:1430-1436, Hinchey,J.A. & Benesch,C., 2000
Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000
The Clinical Spectrum of Anti-GAD Antibody-Positive Patients with Stiff-Person Syndrome
Neurol 55:1531-1535, Dalakas,M.C.,et al, 2000
Motor and Cognitive Improvements in Patients with Huntington's Disease after Neurol Trasnplantation
Lancet 356:1975-1979,1945, Bachoud-Levi,A.,et al, 2000
Early Stroke Treatment Associated with Better Outcome
Neurol 55:1649-1655, Marler,J.R.,et al, 2000
Effect of intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography
Stroke 31:2912-2919, The National Institute of Neurological Disorders a, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000
Can Emergency Department Physicians Safely and Effectively Initiate Thrombolysis for Acute Ischemic Stroke?
Neurol 55:1801-1805, Akins,P.T.,et al, 2000
Dysthyroid Orbitopathy
Semin Neurol 20:43-54, Jacobson,D.M., 2000
Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999
MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999
The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999
Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999